Chimera Investment Corporation (CIM) Earnings Call Transcript & Summary
May 4, 2023
Earnings Call Speaker Segments
Victor Falvo
executiveThanks, operator. I appreciate all of you joining us for Chimera's earnings conference call covering the first quarter of 2023. Prior to getting started, let me go over the safe harbor statements. On today's call, we will make forward-looking statements, meaning predictions, projections, or other statements regarding future events; such statements rest on current expectations and assumptions that carry risks and uncertainties, which are described in the Risk Factors section of our latest annual and quarterly SEC filings. Actual events and results could differ materially from these forward-looking statements. We urge you to read the forward-looking statement disclaimer included in our earnings release as well as our quarterly and annual filings. On today's call, we might also talk about non-GAAP financial measures. Kindly refer to our SEC filings and investor presentation for a reconciliation to the most comparable GAAP measures. The content of this conference call may include time-sensitive information that is accurate only as of the date of this earnings call. We do not undertake and specifically disclaim any obligation to update or revise this information. I'll now hand the conference over to our Chief Executive Officer, Phil Kardis.
Phillip J. Kardis
executiveThanks, Vic. Good morning, and welcome to the first quarter 2023 earnings call for Chimera Investment Corporation. On the line with me are Choudhary Yarlagadda, our President and Co-Chief Investment Officer, Dan Thakkar, our Co-Chief Investment Officer, Subra Viswanathan, our Chief Financial Officer, and Vic Falvo, our Head of Capital Markets. Once I finish my remarks, Subra will go over the financial results, and after that we'll take questions. The first quarter was quite a ride. Some might describe it as a roller coaster. To me, it felt more like the slingshot ride at Coney Island. Even with all that volatility, we got a lot done. We agreed to buy $1.25 billion of diversified mortgage loans, finished 3 securitizations, cut recourse leverage by $237 million, and produced a 2% total economic return. Since the quarter closed, we've finished 4 securitizations, including one we expect to close later today, and cut our recourse leverage by another $400 million, which includes bringing our reperforming loan warehouse exposure down to 0, all in a very difficult environment. Let's take a quick look at what happened during the quarter. The quarter began with the market anticipating a recession by mid-year, based on December economic data. We saw rates moderate, our book value rise, and the securitization market start to open up. The Fed acted as expected on February 1 by slowing the pace of rate hikes to 25 basis points; then on February 3rd, we got whipped the other way when the January employment report showed extraordinary job growth along with upward revisions to last year's jobs data. The news kept coming in the same direction, with higher consumer spending and both headline and core inflation rising in January; in response to this data, Chairman Powell's statement before Congress on March seventh was quite hawkish, raising the possibility that the Fed would go back to larger rate hikes and that the peak rate in the cycle would be higher than previously thought. Soon after his testimony, the July Fed Funds futures contract yield rose to 5.59%, and the market expected that rate to stay throughout the year. Two days later, it was clear Silicon Valley Bank was in deep trouble, and the next day it was put into receivership by the FDIC, and Signature Bank failed over the weekend. The future of Credit Suisse was also hanging over the market; this set off a period of significant volatility in the rates market. The immediate concern was that other regional banks would fail or would need government assistance. Over the next 10 days, the markets responded with the July Fed Funds contract rallying by 110 basis points. Market expectations shifted to easing by the Fed in July. The expected Fed funds rate dipped below 4% by year-end; with both the FDIC and the Fed providing liquidity facilities for the banks, things began to calm. Data released in March showed the labor market remained strong and inflation remained high. The Fed came back with its standard 25 basis point increase. According to fresh dot projections, most Fed officials continued to anticipate a peak funds rate of 5.125%. Markets, however, kept pushing back and had already factored in reductions later in the year. Yesterday, the Fed lifted rates once more by 25 basis points and adjusted its wording to suggest a possible pause at the following meeting. It also indicated that its inflation forecasts do not justify a cut this year. Higher for longer. The slingshot shifts we saw over the quarter produced a few unexpected difficulties. The elevated volatility and spread widening that took place affected both the timing and the completion of securitizations for loans we had agreed to buy early in the quarter. Severe rate swings likewise hurt our longer-dated hedge instruments, generating roughly $34 million of realized derivative losses during the period. The upshot of all this volatility is that although our assets rose in value over the quarter, book value per share declined — by just $0.08, or approximately 1%. Combining that net book value movement with the $0.23 dividend distributed in the first quarter gave us a 2% total economic return for the period. In our view, this shows how strong and resilient our loan portfolio is. Let me walk you through what our business did during the quarter. In January, Chimera issued or exercised its call rights and shut down four existing securitizations, then issued $586 million CIM Trust 2023-R1 along with $137 million CIM Trust 2023-NR1. Through this re-securitization, we moved $150 million out of recourse borrowings and into securitized debt, while bringing in about $90 million of cash. Our average debt cost on that re-securitization came to 6.66%. Each securitization can be called within 2 years, giving us room to refinance the securitized debt if interest rates get better down the road. We pursued these relever transactions for multiple reasons, among them our financing exposure to Credit Suisse. Entering the quarter, we held $168 million of recourse financing with Credit Suisse, and we understood they were leaving the business. The relever encompassed bonds we had previously financed with CS, provided net cash time, and gave us a chance to seek out new credit facilities to take CS's place. Our efforts paid off, allowing us to redeploy the proceeds from the relevers. As with any equity raise, earnings feel a lag until the new funds are completely put to work. As we mentioned on the last earnings call, we committed during the quarter to buy approximately $1.25 billion of mortgages. Breaking down those total commitments, roughly 57% were seasoned Re-Performing Loans, 39% were non-qualified investor mortgage loans, and the rest were Business Purpose Loans; apart from the Business Purpose Loans, every loan was bought intending to finance it over the long term via securitization. When it came to the seasoned RPLs and BPLs, their loan attributes lined up with what we see in our portfolio today. During March, we sponsored CIM 2023-R2, which is a rated securitization of seasoned Re-Performing residential mortgage loans, and it carried a principal balance of $447 million. The securities issued through CIM 2023-R2, totaling roughly $365 million in aggregate balance, went out via private placements to institutional investors. Those senior securities made up around 82% of the capital structure. We kept a subordinate interest in certain interest-only securities, with an aggregate balance of approximately $83 million, for investment purposes. On this securitization, our average cost of debt stands at 5.95%; we held onto an option allowing us to call the securitized mortgage loans at any point starting in March 2028. After the quarter ended, we kept up our securitization work. In April, we sponsored CIM Trust 2023-I1, a rated securitization of non-QM investor mortgage loans, which had a principal balance of $236 million; we additionally exercised call rights and shut down two securitization trusts that already existed, after which we issued CIM Trust 2023-R3 at $451 million and CIM Trust 2023-NR2 at $67 million. Through this re-securitization, we were able to move approximately $150 million out of recourse borrowing and into securitized debt, while bringing in about $40 million in cash; we priced CIM Trust 2023-R4, a rated securitization of seasoned reperforming residential mortgage loans.
Phillip J. Kardis
executiveLater today is when we anticipate that deal will wrap up. The mortgage loans in question encompassed commitments we made in January to buy loans, plus RPLs sitting in our warehouse. Once that deal is finalized, our exposure to RPL warehouse will drop down to 0. At present, we anticipate that the remaining non-QM investor loans will be closed into a securitization sometime in the second quarter. Even with the turbulence the market showed this quarter, we stay optimistic regarding what lies ahead; in our view, the fact that we keep managing to execute on buying loans and securitizing them underscores just how strong Chimera's franchise value is overall. From a credit standpoint, our seasoned reperforming loan portfolio keeps delivering solid results. The recent challenges we've had with EAD stem mainly from what it costs us to finance, rather than from the credit quality of what's in our portfolio, and rather than from the income that portfolio produces, which has slipped slightly compared with a year ago; we'd point out that as soon as rates ease and start coming down, our portfolio sits in a good spot to gain. As rates decline, we anticipate our repo financing will shrink, which should produce a NIM that rises steadily as time goes on. Right now, 14 securitizations we hold can be called during this year. A variety of factors determine when these securitizations get called, among them how much equity can be pulled out, what new investment opportunities are on offer, what new senior securitized debt costs, and how all of it affects our balance sheet and income statements. In our view, this capacity to pull equity out of our investments remains a key differentiator separating Chimera from its peers, and it has the potential to be a major source of capital we can redeploy. Our belief is that our assets are quite strong and that the company sits in a good position for when rates start to ease. Opportunities that are interesting and accretive keep showing up in prime jumbo loans, RPLs, non-QMs, BPLs, and agency RMBS too. Our attention over the last few years has centered on RPLs, yet we anticipate diversifying our investments further as time passes. We recognize that what lies ahead won't be an easy path, yet the new investment opportunities appear appealing, and we stay optimistic regarding what's to come. Our team is excellent, our assets are outstanding, and our vision is clear. At this point I'd like to hand things over to Subra, who will walk through our financial results in greater detail.
Subramaniam Viswanathan
executiveThanks, Phil. Now I'll go over the key financial results for Chimera in Q1 2023. At the close of the first quarter, GAAP book value stood at $7.41 per share, while our economic return on that GAAP book value came to 2%, calculated from the quarterly shift in book value plus the dividend paid on common shares during the first quarter. GAAP net income for Q1 reached $39 million, equal to $0.17 per share. Measured on an earnings available for distribution basis, net income for the first quarter was roughly $31 million, or $0.13 per diluted common share. Economic net interest income in Q1 totaled $69 million. During the first quarter, the yield on average interest earning assets came in at 5.5%. Our average cost of funds was 4.1%, producing a net interest spread of 1.4%. Total leverage for Q1 was 4.1 to 1, and Recourse leverage finished the quarter at 1.2 to 1. Turning to financing and liquidity, the company held $660 million in total cash on unencumbered assets when the quarter ended. On our outstanding repo agreements, we had $1.6 billion featuring either non or limited mark-to-market characteristics; on our outstanding repo liabilities, we carried $2.5 billion in floating rate exposure. As a hedge against our liabilities, we held a $1 billion pay fixed interest rate swap at a rate of 3.26%. Also as a liability hedge, we had $1 billion in swaptions to pay fixed for 1 year starting in March 2024, at an average rate of 3.46%. In addition, the company had $450 million in outstanding short futures contracts, used to hedge loans intended for future securitizations. For the quarter, economic net interest income return on equity was 10.5%, while our GAAP return on average equity was 8.6%. Finally, first quarter 2023 expenses, excluding servicing fees and transaction expenses, totaled $16 million, slightly below the same quarter a year earlier. That wraps up our remarks. We'll now take questions on the call.
Phillip J. Kardis
executiveOperator, we're ready for our questions.
Doug Harter
analystThank you. I was wondering if you might address your approach to the dividend, considering the earnings capacity we have right now and what you expect for earnings once all that capital that's been freed up gets put back to work?
Phillip J. Kardis
executiveHello, Doug, Phil here. Yes, we're aware that what we're paying out right now is more than our EAD. Like we mentioned before, our portfolio, in our view, is solid and stands to benefit as rates start to come down. We're also of the belief that deals that add value will show up in the market. That said, we're mindful that swings in rates and the resulting strains in the banking industry, perhaps even a banking crisis, are generating a significant amount of uncertainty regarding what lies ahead. Even though our outlook stays constructive, we'll be, you know, watching these sorts of trends closely.
Doug Harter
analystUnderstood. Since there's no clarity on when rates will come down, and depending on whether you favor one scenario or the strongest possibility, how do you approach the question of how distant a horizon you use when weighing earnings potential against perhaps holding back some of that capital for investment chances?
Phillip J. Kardis
executiveYeah. Honestly, you captured precisely the way our thinking works. As I noted earlier, the portfolio remains solid. Revenue at the top line remains solid. What's clearly causing pain is our financing costs. We'll be watching how long that situation persists, what genuine investment opportunities exist, and where the market stands, and we'll keep balancing those factors to reach a conclusion. As you put it, at present there's quite a bit of uncertainty. We'll examine all of it and land on the proper balance that we believe serves shareholders best.
Doug Harter
analystAll right. Thanks very much.
Trevor Cranston
analystHi there, and thanks. Could you spend a moment discussing the sorts of chances you're observing that are emerging from bank portfolios — specifically on the whole loan side — and also how much capital you believe is free and available for seizing opportunities of that kind? Alternatively, would you consider boosting leverage in the near term should a major opportunity appear on the market? Thanks.
Phillip J. Kardis
executiveSure, I'll take that one first. As I said, we've got 14 securitizations sitting there with call rights, and we'll evaluate the relevant facts and circumstances; a number of those represent investment possibilities. We might examine leverage as well as alternative capital sources. Regarding what we're currently witnessing, I think I should pass things along to Dan Thakkar, who serves as our Co-Chief Investment Officer.
Dan Thakkar
executiveYeah, Dan Thakkar here. When it comes to those FDIC liquidations, most of it sits in agency RMBS. The position we've adopted at this point is that despite spreads being quite wide, because of the negative technicals in that agency RMBS market, our view is spreads could remain at these levels, and we don't anticipate a near-term catalyst that would drive tightening. What I believe we're attempting right now is putting capital to work whenever it becomes available in non-QM and RPL as well. Is that enough to answer you?
Trevor Cranston
analystYeah, that helps. Thank you. Then regarding warehouse financing, could you provide some broad market commentary on whether any shifts or effects have appeared in the warehouse market, given the banking troubles and the volatility we've witnessed across the past couple of months?
Phillip J. Kardis
executiveWe have not. As of right now, no impact has been observed by us.
Trevor Cranston
analystAll right, thanks.
Bose George
analystHi, everyone, I've just got a single question. Is there any update you can give on book value for the quarter to date?
Phillip J. Kardis
executiveOur view is that it's more or less the same.
Bose George
analystYeah. All right, that's everything from me. Thank you.
Analyst
analystMorning. Ethan is here in place of Eric. Only two questions from my side. I dialed in a few minutes behind, so I apologize if these were already covered. Could you give an estimate of a market yield for the loan portfolio? And how does that stack up against the yield on your cost basis?
Subramaniam Viswanathan
executiveWell, regarding the yield on a cost basis, we show it in our... Apologies, this is Subra Viswanathan speaking now. The yield we report, you know, for the entire portfolio, comes to 5.5%. The bulk of that, clearly, is loans; that figure is on the cost basis. As for, you know, the market yield, I mean, perhaps Dan Thakkar or Chaudry could address the market yield. You know, it truly hinges on the asset class, you know, whether it's RPL or, you know, non-QM investor loans, which is where we've been leaning lately.
Dan Thakkar
executiveYeah. When it comes to unlevered yields within the non-QM space, what we're seeing right now is a current coupon of roughly 8%.
Analyst
analystUnderstood. That's genuinely useful. One final item from my side. When you're doing debt deals, should investors anticipate that you'll purchase defaulted loans from the securitization trust? Or does the plan call for keeping those loans inside the trust until things get resolved? And on a broader note, how much liquidity might you require to back your delinquent pipeline?
Phillip J. Kardis
executiveBroadly, Phil here. Broadly, the sole circumstance in which you'd have to repurchase on our securitizations is when specific rep and warranty breaches occur. When a loan turns delinquent, our expectation is that the servicer will pursue loss mitigation techniques; with some of our securitizations, an asset manager actually oversees things and gives them support. If it reaches the point where the loan moves into foreclosure in the REO, well, it simply gets liquidated inside the trust.
Analyst
analystExcellent; that answers my questions. I have nothing further.
Phillip J. Kardis
executiveOkay. Thanks.
Phillip J. Kardis
executiveOkay, Phil Cartus here. Thanks for being with us on this earnings call for the first quarter of 2023. We’re looking forward to talking with you again later this year.
Operator
operatorThanks. That brings today's call to a close. We appreciate everyone for joining in. At this point, feel free to drop off your lines, and enjoy the rest of your day.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Chimera Investment Corporation transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →For developers and AI pipelines
Programmatic access to Chimera Investment Corporation earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Chimera Investment Corporation or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.